# Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

> **NCT03968744** · PHASE4 · TERMINATED · sponsor: **Alain Kaelin** · enrollment: 11 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease (at Later Stage)

## Interventions

- **DRUG:** Safinamide

## Key facts

- **NCT ID:** NCT03968744
- **Lead sponsor:** Alain Kaelin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-18
- **Primary completion:** 2026-02-02
- **Final completion:** 2026-02-02
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** insufficient eligible patients for enrollment
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03968744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03968744, "Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03968744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*